Animal Models Grants

American College of Cardiology Foundation Young Investigators Awards Competition

The purpose of the YIA Awards is to encourage and recognize young scientific investigators of promise, upon whom progress in the field of cardiology is dependent. A manuscript and abstract summarizing any problem that relates to cardiovascular disease whether it be in etiology, pathophysiology, diagnosis, or therapy. YIA Award Categories:

1) Clinical Investigations in Cardiology, Congenital Heart Disease and Cardiovascular Surgery. Awards in this category are meant for investigations that cover clinical investigations with health related outcomes as primary objectives. Large population based epidemiologic investigations including population genetics would fall in this category this year.

2) Physiology, Pharmacology, and Pathology
These awards are meant for investigators wishing to submit a project related to coronary and vascular physiology, pathology and pharmacology in humans or animals that address mechanisms of disease and aspects related to mechanism of action of therapies. Molecular physiologic and biochemical approaches that enhance the interface between basic and clinical aspects of cardiovascular disease, shed light on a physiologic or biochemical mechanism(s) would fall in this category.

3) Molecular and Cellular Cardiology.
These awards are meant for investigators addressing basic aspects of molecular and cellular regulation as it pertains to the cardiovascular system. These projects are typically basic investigations and seek to probe fundamental questions pertaining to development, differentiation and do not readily fall into the previous categories.

Elegibility
Any physician/scientist presently in a residency or a fellowship training program or who has been in such a program within the past three years; medical students; and Ph.D. candidates.

The Award
The first place winner for each category receives $2,000, second place winners receive $1,000; three honorable mentions in each category receive $500. Travel, hotel and meals up to $1500 will be reimbursed for all 15 finalists to attend the YIA Competition at the ACC.11.

Support for the ACCF/Herman K. Gold Young Investigator Awards in Molecular and Cellular Cardiology is provided by a grant from CVPath Institute and the family of Herman K. Gold.

Application Deadline: October 14, 2010

For More Information about these Awards, contact Kelli Bohannon at 800-253-4636, ext. 6635 or email her at kbohanno@acc.org

Society of Toxicology Syngenta Fellowship Award in Human Health Applications of New Technologies

The Syngenta Fellowship Award in Human Health Applications of New Technologies is presented to either a third year (or later) graduate student or a postdoctoral trainee. The funding ($15,000) is to support mode-of-action research aimed at characterizing dose-dependent effects of xenobiotics on mammalian systems in such a way that the causal sequence of key events underlying toxicity is elucidated. The work should permit a quantitative basis for extrapolation of the results from animal bioassays or animal models (in silico, in vitro) to humans at relevant human doses. The awardee will receive funding to travel to the SOT Annual Meeting to accept the award and for travel to a Syngenta facility to present the results. This is a one year, non-renewable award.

The award consists of a plaque, fellowship funds, travel to the SOT meeting to accept the award, and travel to a Syngenta site to present the results.

Criteria for award:

* Third year (or later) graduate student or postdoctoral trainee employed by academic institution, federal/national laboratory, or research institute
* Applicant is member of the Society, or membership is pending at application deadline. Does not have to be a member (if not a member, awardee will apply before the fellowship is conferred).

Items needed in the application:
1. Application form, which includes:
A.Budget
B.Brief project description
C.Candidates to articulate how their work provides data that will permit a quantitative basis for extrapolation of the results from animal studies to human at relevant human doses.
2. Graduate transcripts
3. Copies of up to three of the applicant's publications or abstracts if available.

Apply by downloading application files from the SOT Web site, completing, and uploading the files to the SOT Awards page.

4. Reference form and letter from research director
5. Reference form and second letter of reference
6. Reference form and third letter of reference
Letters of reference are e-mailed directly by the writer to sotadmin@toxicology.org.

Mail a hard copy of the signed application form to:

Syngenta Fellowship Award
Society of Toxicology
1821 Michael Faraday Drive, Suite 300
Reston, VA 20190

Letters of reference are e-mailed directly by the writer to SOT HQ.

Deadline October 9, 2010

Society of Toxicology
1821 Michael Faraday Drive, Suite 300
Reston, VA 20190

Phone (703) 438-3115
Fax (703) 438-3113

Muscular Dystrophy Association Research Infrastructure Grant

The Infrastructure Grant is designed to fund the development of infrastructure — tools, techniques or services — that will be of use to the neuromuscular disease research community for the purpose of therapy development. Although the need for the proposed infrastructure can be presented in the context of a specific research project or projects, the grant will ultimately be evaluated on the need for the infrastructure by the community at large, and on the applicant’s specific plan for making this resource available to the community. Collaboration and compatibility of the proposal with relevant existing infrastructure is encouraged.

Letter of Intent: September 15, 2010
Grant Application: October 15, 2010
Start Date: July 1, 2011

The applicant should be a professional or faculty member at an appropriate educational, medical or research institution who is qualified to conduct and supervise a program of original research. The applicant should hold a Doctor of Medicine, Doctor of Philosophy, Doctor of Science or equivalent degree.

Examples of acceptable infrastructure projects include, but are not limited to, development of databases, core facilities (e.g., vector production, muscle imaging, drug screening), microarray chips, animal model resources, tissue repositories, and components of clinical research networks.

Contact
Elizabeth Habeeb-Louks
3300 E. Sunrise Drive
Tucson, AZ 85718
(520) 615-6704
(520) 529-5454 (fax)
elouks@mdavp.org